<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured serum alpha 1-antichymotrypsin levels in 38 patients with Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo>, 89 control subjects, 2 subjects with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down's syndrome</z:e>, 20 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 18 with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, 14 with <z:hpo ids='HP_0002503'>spinocerebellar degeneration</z:hpo>, 15 with cerebrovascular disease without <z:hpo ids='HP_0000726'>dementia</z:hpo>, and 14 with Duchenne <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cerebrospinal fluid (CSF) levels of alpha 1-antichymotrypsin were also measured in 15 patients with Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo>, 26 control subjects, 6 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, 7 with cerebrovascular disorder, and 11 with <z:e sem="disease" ids="C1285162" disease_type="Disease or Syndrome" abbrv="">degenerative disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In control subjects, there were no age-related changes or sex differences </plain></SENT>
<SENT sid="3" pm="."><plain>Serum and CSF levels were significantly and specifically higher in patients with Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo> than in other subjects (serum, p less than 0.001; CSF, p less than 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Serum levels of alpha 1-antichymotrypsin were significantly elevated in the early stage of Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo>, whereas there was no definite correlation between serum levels and the degree of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>CSF levels of alpha 1-antichymotrypsin tended to parallel the severity of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Serum levels were not correlated with CSF levels </plain></SENT>
<SENT sid="7" pm="."><plain>These data indicate that serum and CSF levels of alpha 1-antichymotrypsin might be independently upregulated in Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>We concluded that the measurement of serum levels of alpha 1-antichymotrypsin could be useful as a screening marker for Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, CSF levels also could be a useful marker for Alzheimer-type <z:hpo ids='HP_0000726'>dementia</z:hpo>, because they might reflect the state of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>